Trial in Progress: A Phase II Window of Opportunity Study of the BCMAxCD3 Bispecific Antibody REGN5458 in Previously Untreated Patients with Symptomatic Multiple Myeloma
| Autor: | Ferreri, Christopher J., Quatela, Steven E. *, Aina, Sean *, Roy, Pourab *, Boyapati, Anita *, Rodriguez Lorenc, Karen, Kroog, Glenn S. *, Orlowski, Robert Z. |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:10129-10130 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|